AL3810, a multi-tyrosine kinase inhibitor, exhibits potent anti-angiogenic and anti-tumour activity via targeting VEGFR, FGFR and PDGFR

✍ Scribed by Yuanfeng Zhou; Yi Chen; Linjiang Tong; Hua Xie; Weiwei Wen; Jie Zhang; Yong Xi; Yanyan Shen; Meiyu Geng; Yuanyuan Wang; Hualiang Jiang; Cheng Luo; Liping Lin; Jian Ding

• Book ID: 119857640
• Publisher: Carol Davila University of Medicine Bucharest, Romania
• Year: 2012
• Tongue: English
• Weight: 451 KB
• Volume: 16
• Category: Article
• ISSN: 1582-1838
• DOI: 10.1111/j.1582-4934.2012.01541.x